Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

TCT 665: Endocardial radiofrequency septal ablation before TAVI: A novel approach to prevent suicide ventricle

Presentation TCT 2022

TCT 665: Endocardial radiofrequency septal ablation before TAVI: A novel approach to prevent suicide ventricle

Presenter: Bruno Valdigem

September 19, 2022

TCT 681: Alcohol Septal Ablation for Preoperative Optimization Prior to Noncardiac Surgery in Hypertrophic Cardiomyopathy

Presentation TCT 2022

TCT 681: Alcohol Septal Ablation for Preoperative Optimization Prior to Noncardiac Surgery in Hypertrophic Cardiomyopathy

Presenter: Sina Salehi Omran

September 18, 2022

TCT 646: Emergent Alcohol Septal Ablation for Severe Outflow Tract Obstruction while Pregnant and on V-V ECMO for COVID ARDS

Presentation TCT 2022

TCT 646: Emergent Alcohol Septal Ablation for Severe Outflow Tract Obstruction while Pregnant and on V-V ECMO for COVID ARDS

Presenter: Michael Hannon

September 18, 2022

TCT 214: Single Ablation Renal Denervation – The RADAR Study Experience with the Metavention iRF System

Presentation TCT 2022

TCT 214: Single Ablation Renal Denervation – The RADAR Study Experience with the Metavention iRF System

Presenter: Horst Sievert

September 17, 2022

Percutaneous Intramyocardial Septal Radiofrequency Ablation (PIMSRA) for Hypertrophic Obstructive Cardiomyopathy: Results From the First 200 Patients

Presentation TVT 2022

Percutaneous Intramyocardial Septal Radiofrequency Ablation (PIMSRA) for Hypertrophic Obstructive Cardiomyopathy: Results From the First 200 Patients

Presenter: David Hsi

June 09, 2022

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Presentation ACC 2022

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Presenter: Milind Y Desai

April 03, 2022

Current status of the REBALANCE-HF US FDA randomized feasibility clinical trial in HFpEF

Presentation THT 2022

Current status of the REBALANCE-HF US FDA randomized feasibility clinical trial in HFpEF

Presenter: Sanjiv Shah

February 01, 2022

Long-term follow-up on FIH experience using the Satera Ablation System in HFpEF and HFrEF

Presentation THT 2022

Long-term follow-up on FIH experience using the Satera Ablation System in HFpEF and HFrEF

Presenter: Sanjiv Shah

February 01, 2022

Overview of the physiology of the splanchnic bed in HFpEF and HFrEF

Presentation THT 2022

Overview of the physiology of the splanchnic bed in HFpEF and HFrEF

Presenter: Marat Fudim

February 01, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.